A recent review on existing cannabis studies only suggest two pediatric uses for medical marijuana: relieving chemotherapy-induced nausea and vomiting and and reducing seizures.
A systemic review of published researches on cannabis use among children and adolescents were conducted by Massachusetts General Hospital (MGH) investigators Shane Shucheng Wong, MD, and Timothy Wilens, MD — both of the MGH Department of Psychiatry.
The researchers followed standard procedure on selecting those studies indexed in major researches and from them, pulled out ones that was participated by subjects aged 18 and below.
They successfully extracted 21 papers that met their criteria, all published within 1979 to 2017. Only five, however, were randomized controlled trials with the most common conditions studied being chemotherapy-induced nausea and vomiting, and seizures.
Studies into these conditions showed significant promise of the drug’s potential for treatment but the researchers highlighted major limitations such as small sample sizes, the lack of control groups, and lack of long term follow ups, among others.
Although there have been reports on the use of marijuana for spasticity, neuropathic pain, post-traumatic stress disorder or Tourette syndrome, all these lacked controls leading the researchers to dismiss these in their conclusion.
A necessary knowledge
Today, 29 US states and D.C. have given the legal nod to the use of marijuana for medical purposes although there have been very limited studies on the drug.
The researchers advise parents considering marijuana as a treatment option for their children to consult an experienced and knowledgeable professional first before they finalize the decision.
You can read the full paper in the journal Pediatrics.